Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Its part of a class of drugs called glucagon-like peptide 1 (GLP-1) receptor agonists, which help people with Type 2 diabetes lower their blood sugar and reduce their risk for cardiovascular disease
Retatrutide's triple receptor target aims for higher efficacy compared to Tirzepatide's dual-receptor approach
This seems trivial until you have multiple vials and cannot remember which one is 10mg/ml and which is 20mg/ml
Tirzepatide slows gastric emptying slightly more than semaglutide at equivalent GLP-1 receptor activation levels (Urva et al., Clinical Pharmacology & Therapeutics 2022)
US$ 20.49
US$ 28.21
US$ 24.14
